Is NCEL or NGEN more undervalued in 2026?

CirclFi compares NewcelX Ltd. (NCEL) and NervGen Pharma Corp. (NGEN) using 13 institutional-grade valuation models. NCEL has a Quality of Company score of 1.7/10 while NGEN scores 3.1/10.

Which is a better buy — NCEL or NGEN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NCEL and NGEN valuations compare?

NCEL at $3.54 and NGEN at $2.08 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NCEL vs NGEN Valuation Comparison 2026 — Intrinsic Value Analysis

NCEL

Biotechnology

NewcelX Ltd.

Quality

1.7

out of 10

Value Trap

SAFE

Price

$3.54

Last close

Models

7/13

Active

NGEN

Biotechnology

NervGen Pharma Corp.

Quality

3.1

out of 10

Value Trap

—

Price

$2.08

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	NCEL Fair Value	NCEL Upside	NGEN Fair Value	NGEN Upside
Bayesian DCF	Intrinsic	$0.94	-73.5%	$0.64	-69.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.53	-55.6%	$0.09	-95.6%
PWERM	Option-Based	$2.43	-29.5%	$2.11	+1.4%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NCEL vs NGEN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NCEL vs NGEN — Which Stock Is More Undervalued?

NGEN scores higher with a 3.1/10 quality rating vs NCEL's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NewcelX Ltd. (NCEL) and NervGen Pharma Corp. (NGEN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NCEL currently trades at $3.54 with a QOC of 1.7/10, while NGEN trades at $2.08 with a QOC of 3.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).